The Scientific Committee to Combat Corona at the Ministry of Health and Population has agreed to start providing pharmacies in the Republic with the drug “molnopiravir” to treat corona, which is being offered by more than one company, as the first antiviral in the world targeting the emerging corona virus and its new variants.
Hossam Hosni, head of the Scientific Committee to Combat Corona at the Ministry of Health, said in statements for the seventh day that the drug achieved amazing results following it was included in the therapeutic protocol recently issued by the committee, which prompted them to provide it in pharmacies in the Republic for use in treating home-isolated patients treated from the emerging corona virus..
Hossam Hosni added that the drug is 40 capsules in one box, used in the patient’s “treatment course” for 5 days, at a cost of 420 pounds per package, which is the period that the patient needs to overcome the Corona virus and the “Omicron” mutant prevailing in Egypt and the world at present..
And Dr. Jihan Al-Assal, Professor of Chest Diseases at Ain Shams University and Vice Chairman of the Scientific Committee to confront the emerging corona virus, confirmed that the drug can be taken by Corona patients, especially those at high risk of simple and medium cases..